Neuromielitis óptica y lupus eritematoso sistémico en un hombre: Caso clínico

por Suárez H,Felipe, Urrutia E,Daniela, Canales P,Felipe, Gutiérrez O,Camila
Publicado 2016

Neuromyelitis Optica (NMO) in Children: A Rare Case Report

por Dodik Tugasworo, Aditya Kurnianto, Retnaningsih Retnaningsih, Yovita Andhitara, Rahmi Ardhini, Tomy Nugroho, Jethro Budiman
Publicado 2020

No association of AQP4 polymorphisms with neuromyelitis optica and multiple sclerosis

por Yang Ting-Ting, He Yang, Xiang Ya-Juan, Ao Dong-Hui, Wang Yang-Yang, Zhang Qi, He Xiang-Jun, Zhong Shan-Shan, Wu Jian, Liu Guang-Zhi
Publicado 2016

Comparison of Early- and Late-Onset NMOSD-Related Optic Neuritis in Thai Patients: Clinical Characteristics and Long-Term Visual Outcomes

por Thongmee W, Narongkhananukul C, Padungkiatsagul T, Jindahra P, Vanikieti K
Publicado 2021

Prognostic Factors for Visual Outcomes Following the First Episode of NMOSD-Related Optic Neuritis in Affected Eyes

por Thongmee W, Padungkiatsagul T, Jindahra P, Khongkhatithum C, Thampratankul L, Vanikieti K
Publicado 2020

MOG-IgG- versus AQP4-IgG-Positive Optic Neuritis in Thailand: Clinical Characteristics and Long-Term Visual Outcomes Comparison

por Narongkhananukul C, Padungkiatsagul T, Jindahra P, Khongkhatithum C, Thampratankul L, Vanikieti K
Publicado 2020

Quantitative Susceptibility Mapping-Derived Radiomic Features in Discriminating Multiple Sclerosis From Neuromyelitis Optica Spectrum Disorder

por Zichun Yan, Huan Liu, Xiaoya Chen, Qiao Zheng, Chun Zeng, Yineng Zheng, Shuang Ding, Yuling Peng, Yongmei Li
Publicado 2021

MRI Prognostic Factors in Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, and Myelin Oligodendrocyte Antibody Disease

por Rosa Cortese, Antonio Giorgio, Gianmarco Severa, Nicola De Stefano
Publicado 2021

Etiologies of Acute Optic Neuritis in Thailand: An Observational Study of 171 Patients

por Vanikieti K, Janyaprasert P, Lueangram S, Nimworaphan J, Rattanathamsakul N, Tiraset N, Chokthaweesak W, Samipak N, Padungkiatsagul T, Preechawat P, Poonyathalang A, Pulkes T, Tunlayadechanont S, Siriyotha S, Jindahra P
Publicado 2020

Successful treatment for psychomotor agitation in neuromyelitis optica spectrum disorder with trazodone–risperidone combination: a case report

por Narita Z, Takano H, Sumiyoshi T
Publicado 2017

Interleukin-6: evolving role in the management of neuropathic pain in neuroimmunological disorders

por Kenichi Serizawa, Haruna Tomizawa-Shinohara, Shota Miyake, Kenji Yogo, Yoshihiro Matsumoto
Publicado 2021

Comprehensive Analysis of N6-Methyladenosine (m6A) Methylation in Neuromyelitis Optica Spectrum Disorders

por Hong Yang, Yi-Fan Wu, Jie Ding, Wei Liu, De-Sheng Zhu, Xia-Feng Shen, Yang-Tai Guan, Yang-Tai Guan
Publicado 2021

Abnormal Baseline Brain Activity in Neuromyelitis Optica Patients Without Brain Lesion Detected by Resting-State Functional Magnetic Resonance Imaging

por Liu Y, Xiong H, Li X, Zhang D, Yang C, Yu J, Liao R, Zhou B, Huang X, Tang Z
Publicado 2020

Complexity and wide range of neuromyelitis optica spectrum disorders: more than typical manifestations

por Han J, Yang M, Zhu J, Jin T
Publicado 2017

Neutrophil-to-Lymphocyte Ratio on Admission is an Independent Risk Factor for the Severity of Neurological Impairment at Disease Onset in Patients with a First Episode of Neuromyel...

por Zhou Y, Xie H, Zhao Y, Zhang J, Li Y, Duan R, Yao Y, Jia Y
Publicado 2021

Comparison of spontaneous brain activity revealed by regional homogeneity in AQP4-IgG neuromyelitis optica-optic neuritis versus MOG-IgG optic neuritis patients: a resting-state fu...

por Wang J, Tian Y, Shao Y, Feng H, Qin L, Xu W, Liu H, Xu Q, Wei S, Ma L
Publicado 2017